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Human platelet lysate (PL) is a cost-effective and human source of autologous multiple and potent
pro-angiogenic factors, such as vascular endothelial growth factor A (VEGF A), fibroblast growth factor
b (FGF b) and angiopoietin-1. Nanocoatings previously characterized were prepared by layer-by-layer
assembling incorporating PL with marine-origin polysaccharides and were shown to activate human
umbilical vein endothelial cells (HUVECs). Within 20 h of incubation, the more sulfated coatings induced
the HUVECS to the form tube-like structures accompanied by an increased expression of angiogenic-
associated genes, such as angiopoietin-1 and VEGF A. This may be a cost-effective approach to modify
2D/3D constructs to instruct angiogenic cells towards the formation of neo-vascularization, driven by
multiple and synergistic stimulations from the PL combined with sulfated polysaccharides.
Statement of Significance
The presence, or fast induction, of a stable and mature vasculature inside 3D constructs is crucial for new
tissue formation and its viability. This has been one of the major tissue engineering challenges, limiting
the dimensions of efficient tissue constructs. Many approaches based on cells, growth factors, 3D
bioprinting and channel incorporation have been proposed. Herein, we explored a versatile technique,
layer-by-layer assembling in combination with platelet lysate (PL), that is a cost-effective source of many
potent pro-angiogenic proteins and growth factors. Results suggest that the combination of PL with
sulfated polyelectrolytes might be used to introduce interfaces onto 2D/3D constructs with potential
to induce the formation of cell-based tubular structures.
 2015 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.1. Introduction
The development of tissue engineering constructs containing a
functional and mature pre-vasculature is still a major challenge
[1–3]. In the absence of such a network, the viability and regenera-
tion potential of thick constructs will be compromised due to the
limitation of nutrients and cell debris diffusion. In order to over-
come this issue, researchers have been recurring either to
material-based and cell-based approaches aiming to create an ade-
quate vasculature inside engineered constructs. Material-based
approaches have been focusing on the development of cellular or
acellular 3D organized vessel-like structures through microfabrica-
tion and customized cell seeding methodologies [4,5]. On the otherhand, cell-based approaches have been centered the instruction
and activation of the involved angiogenic cells (e.g., endothelial
and pericytes) to lead their cellular assembling into stable cellular
tubular networks (i.e., tubulogenesis). The specific instruction of
endothelial cells (EC) towards the formation of stable tube-like
structures (TLS) has been extensively investigated [6,7]. Natural
or synthetic extracellular cues such as collagen, fibrin, growth fac-
tors (GFs) or similar epitopes, are known to activate specific integ-
rins and tyrosine kinase receptors, efficiently promoting angiogenic
cells activation and formation of TLS. However, most of those
instructive cues/constructs are frequently obtained from animal-
origin and costly sources, or need complicated procedures. The for-
mation of neo-vessels involves a complex crosstalk between several
cell types, platelets releasates, extracellular matrix and their
secreted pro and anti-angiogenic factors. Vascular endothelial
growth factor (VEGF) and fibroblast growth factor b (FGFb) are con-
sidered the most potent angiogenic GFs being frequently used to.1016/j.
2 S.M. Oliveira et al. / Acta Biomaterialia xxx (2015) xxx–xxxprepare angiogenic biomaterials. The angiogenesis is initiated and
regulated by several cells types, GFs and other bioactive proteins
and environmental cues such as hypoxia [8]. The ECs are activated,
proliferate, migrate and, in the final stage, their tubular structures
are stabilized by pericytes, smooth vascular cells and synthetized
ECM [8].
Recent works have been highlighting the importance of the pro-
vision of multiple GFs in order to achieve better networks regard-
ing size features and stability [1,9–12]. This has been explored by
the combination of multiple recombinant GFs or other cell types
able to provide such bioactive moieties to the EC. Platelets, natural
players in the healing process, are very attractive sources of multi-
ple GFs, metalloproteinases and other potent regulators of angio-
genesis [13].
The ability of platelets derivatives to stimulate ECs prolifera-
tion, migration and enhance in vitro and in vivo angiogenesis has
been recently reported [9,14–20]. These features has been mainly
attributed to platelet-rich-plasma (PRP). PRP has been mixed with
biomaterials [9,18,19], adsorbed onto scaffolds [20], used as
PRP-gel [17] or by itself [14–16]. Moreover, reports have shown
that PRP, used as extract in GFs-reduced Matrigel, can promote
the formation of tube-like structures (TLS) of ECs within less than
24 h, which reinforces its angiogenic potential [14–16]. However,
Matrigel or other similar rich basement membranes are from ani-
mal sarcoma origin, thus are not considered a suitable option for
human application [21].
Herein, we propose the reconstruction of angiogenic nanobase-
ment membranes-like constructs by using platelet lysate (PL) – as a
source of multiple angiogenic factors-, marine-origin polysacchar-
ides – as stabilizers -, and layer-by-layer assembling (LbL) – for a
controlled assembling – Fig. 1a. PL was obtained by lysing human
platelet concentrates by freezing-thawing cycles – Fig. 1b.
LbL is a simple and versatile technique comprising the
alternated deposition of polyelectrolytes (PEs) interacting by
electrostatic, or other types of interactions, and can be performed
under mild conditions [22–24]. In order to achieve an efficient EC
activation mediated by GFs, their stability, conformation and
density presented to the cells must be adequate. Moreover, the type
of binding between the GF and their stabilizer will affect the
intracellular signal transduction [25] – Fig. 1c. Under this context,Fig. 1. Schematic representation of the approach followed. (a) PL preparation. (b) Layer-
endothelial cells (ECs) during 20 h on the nanocoatings and expected interaction throug
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assess the pro-angiogenic potential of the nanocoatings, human
umbilical vein ECs (HUVECs) adhesion, proliferation, morphology
and gene expression were analyzed.
2. Materials and methods
2.1. Materials
Medium molecular weight chitosan (Chi), with a degree of
deacetylation of 80% (Sigma Aldrich, MKBB0566), was purified by
a re-precipitation method. Briefly, Chi powder was dissolved in
2% (v/v) acetic acid solution with 1% (w/v) concentration. The mix-
ture was stirred overnight at room temperature. The impurities
were removed by four filtration cycles. Then, Chi was precipitated
by addition of 1 M NaOH while stirring. Final steps consisted on
washing Chi with distilled water until reaching a neutral pH and
on Chi dehydration rising with ethanol–water mixtures with
increasing ethanol content (20–100% v/v). Chi was freeze-dried
for 3 days and ground. j- (Sigma–Aldrich, 22048), i- (Fluka,
22045), k-carrageenan (Car; Sigma–Aldrich, 22049), sodium
heparin (Hep; Sigma–Aldrich, H3149), sodium alginate (Alg; Sigma
Aldrich, 250 cP), and poly(ethyleneimine) solution (PEI; Sigma–
Aldrich, P3143) were used as received.
2.2. Materials preparation
2.2.1. Preparation of platelet lysate
Platelet concentrates were obtained from different platelet col-
lections performed at Instituto Português do Sangue (IPS, Porto,
Portugal), under a previously established cooperation protocol.
The components were obtained using the Trima Accel Automated
Blood Collection System. All the platelet products were biologically
qualified according to the Portuguese legislation. The platelet
count was performed at the IPS using the COULTER LH 750
Hematology Analyzer and the sample volume adjusted to
1 million platelet lL1. The collected samples were subject to three
repeated temperature cycles (frozen with liquid nitrogen at
196 C and heated at 37 C) and frozen at 20 C until further
use. The remaining platelets were eliminated by centrifugation atby-Layer assembling onto tissue culture polystyrene (TCPS) surfaces. (c) Culture of
h VEGF, FGF, Angiopoietin-1 and other receptors.
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20 C until final use. This procedure has not jeopardized growth
factors bioactivity [26].
2.2.2. Polyelectrolytes solutions
j-, i-, k-Car, Hep and Alg were prepared in 1 M Tris HCl 40 nM
NaCl pH 7.4 at a concentration of 0.5 mg mL1. Chi was dissolved in
sodium acetate buffer at a concentration of 0.5 mg mL1. PL was
10-fold diluted with Tris HCl buffer for the multilayers with Car,
Hep and Alg, or with 1 M sodium acetate 40 mM NaCl pH 6 to be
combined with Chi.
2.2.3. Coatings preparation in 48-well plates
In order to prepare coatings with 6 bilayers of the pairs Alg/PL,
Chi/PL, jCar/PL, iCar/PL, kCar/PL and Hep/PL, all 48-well plates
were modified with 0.5 mL of 0.5% (w/v) PEI solution to confer a
positive surface charge. Then, the solution was removed and the
wells were extensively rinsed with distilled water in order to
remove the unbound PEI. LbL assembling was started by the
adsorption of the negative PE. In the case of Chi, an Alg layer was
first adsorbed which was followed by Chi. The adsorption times
and volumes used were: 4 min and 0.5 mL for the polysaccharides
solutions; 0.5 mL and 10 min for the PL solution; intermediate ris-
ing steps x2 for 30 s using the respective buffers. The sequence was
repeated 1, 3 or 6 times. The well plates were let to air-dry over-
night and then sterilized using a UV light for 40 min.
2.3. Cell behavior assessment
2.3.1. HUVECs isolation
Human umbilical cords obtained after caesarean sections from
healthy donors were provided by Hospital de S. Marcos, Braga, Por-
tugal. They were delivered in transport buffer, containing 0.14 M
NaCl, 0.004 MKCI and 0.011 M glucose in 0.001 M phosphate buffer
at pH 7.4. Human umbilical cord vein endothelial cells (ECs)
(HUVECS) were isolated as described in literature by Jaffe and
others [1].
Biological samples were provided under a protocol approved by
the Hospitals Ethical Committees and the 3B’s Research Group.
Cells were expanded using M199 supplemented with 50 lg/mL
endothelial cell growth supplement (ECGS, BDBiosciences),
50 lg/mL of heparin, 3.4 ll/mL Gibco GlutaMAXTM (Life Technolo-
gies) and 20% fetal bovine serum (FBS). Cells were cultured at
37 C, 5%CO2, 99% humidity and medium was exchanged every
2–3 days. HUVECs from two different donors and between passage
4 and 7 were used in the experiments.
2.3.2. Cell culture
To proceed with the cell seeding, expanded cells were harvested
by trypsinization and filtered with a 100 lm cell strainer to
remove possible cell aggregates. Different cell densities were
prepared: 20,000 cells/mL with 0% FBS, 20,000 cells/mL with
10% FBS, 20,000 cells/mL with 20% FBS for cell adhesion and
proliferation quantification; 100,000 cells/mL, 200,000 cell/mL,
300,000 cells/mL with 10% FBS for cell morphology studies. A
volume of 500 lL of cell suspension was dispensed into each well.
Well-plates were incubated for 20 h. After that, medium was
replaced with fresh one with 10% FBS, ECGS and sodium heparin
for proliferation quantification. Medium without ECGS and sodium
heparin was used as control.
For FGF/VEGF blockage test, M199 medium was supplemented
with 10% FBS and DMSO or FGF/VEGF Receptor Tyrosine Kinase
Inhibitor (PD173074, Santa Cruz Biotechnology), dissolved in
DMSO. According with the manufacturer, it is (N-[2-[[4-(Diethyl-
amino)butyl]amino]-6-(3,5-dimethoxyphenyl)pyrido[2,3-d]pyrimi-Please cite this article in press as: S.M. Oliveira et al., Platelet lysate-based pro-a
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VEGF and FGF receptors.
HUVECs (50,000 cells/500 uL) were seeded onto 1 cm2-coated
well plates and cultured for 20 h in medium supplemented with
150 nM (0.0075% in DMSO) or 200 nM (0.01% in DMSO) of inhibitor
and only DMSO (0.0075% and 0.01%).
2.3.3. Cytoskeleton staining
After 20 h or 4 h in culture, samples were gently rinsed twice
with sterile PBS and then fixed with formalin 10% (v/v) during
20 min. Cells were permeabilized with 0.5 mL of Triton 0.2% (v/v)
in PBS during 2 min and then rinsed with PBS. Samples were
incubated in the dark with 100 lL of (1:100) Phalloidin-TRITC
(Sigma–Aldrich) solution for 30 min and then washed with PBS.
For cell nuclei staining, well plates were incubated in the dark
for 5 min with 100 lL 4,6-diamino-2-phenyindole dilactate (DAPI,
Sigma–Aldrich) diluted 1:1000 in PBS. Samples were observed
using an inverted Axio Observer Fluorescence Inverted Microscope
(Zeiss, Germany) and random images recorded for analysis.
2.4. Image analysis
2.4.1. Angiogenesis analyzer
Angiogenesis Analyzer, a toolset of Image J software, allowed
the analysis of cellular networks.
The total length of the tube-like structures, number of nodes
and of master nodes, number of meshes and of master meshes
were quantified on cytoskeleton fluorescence images of HUVECs
after 20 h of culture. A node was defined as pixels that have at least
3 neighbors, corresponding to a bifurcation. A junction was consid-
ered a node or fused nodes. The segments correspond to elements
that were limited by two junctions/nodes while the branches were
elements delimited by a junction and one extremity. The master
segments were considered pieces of three, delimited by two
junctions, but not exclusively implicated with one branch (master
junctions). The master junctions linked at least 3 master segments.
The meshes were defined as areas enclosed by the segments or
master segments.
2.4.2. Cell profiler
Cell Profiler [43] allowed analysing the morphological changes
of HUVECs when cultured for 20 h on coatings, in the presence or
absence of inhibitors. was Eccentricity, form factor and major
and minor axis length features available with Cell Profiler analysis
were used. The values of eccentricity is defined as the ratio of the
distance between the foci of the considered ellipse and its major
axis length. The values vary between 0 and 1. Values equal to zero
are actually circles while ellipses with eccentricity of 1 are lines.
The form factor was calculate as 4p(Cell Area)/(Cell Perimeter)2,
where 1 represent a perfect circular cell. The major and minor axis
length (in pixels) correspond to the major and minor axis of the
ellipse, respectively. The images used for Cell Profiler analyses
were the same as for Angiogenesis Analyzer.
2.5. dsDNA quantification
In order to quantify cell attachment after 20 h and proliferation
up to 4 days in culture, dsDNA was quantified using the Quant-iTTM
PicoGreen dsDNA assay kit (Molecular Probes/Invitrogen) follow-
ing the manufacturer instructions. After the incubation periods,
the well plates were gently rinsed once with sterile PBS. Then,
1 mL of ultra-pure sterile water added and kept at 80 C until
quantification. For the quantification, samples were defrosted at
room temperature and the fluorescence was read in a microplate
reader at an excitation wavelength of 485 nm and emission
wavelength of 528 nm. A standard curve was created by varyingngiogenic nanocoatings, Acta Biomater. (2015), http://dx.doi.org/10.1016/j.
4 S.M. Oliveira et al. / Acta Biomaterialia xxx (2015) xxx–xxxthe concentration of standard dsDNA standard from0 to 2 mg mL1.
dsDNA values of the sampleswere read off from the standard graph.
At least five specimens were measured per each sample.
2.6. Real time RT-PCR
The quantification of angiogenic gene expression (Table 1) of the
HUVECS cultured on the coatings and on TPCS during 20 h, was per-
formed using quantitative PCR by a two-step fluorogenic assay
using the PerfeCtaTM SYBR Green System (Quanta Biosciences).
The total RNA was extracted using the TRI Reagent
(Sigma–Aldrich), following the manufacturer’s instructions and
then quantified using Nanodrop ND-100 spectrophotometer
(thermo Scientific). First-strand complementary DNA (cDNA) was
synthetized using 1 lg RNA of each sample and the qScriptTM
cDNA Synthesis Kit (Quanta Biosciences) for a 20 lL reaction. The
obtained cDNA was used as a template for the amplification of
the target genes using aMasterCycler EP Gradient detection System
(Eppendorf) thermocycler and the PerfeCtaTM SYBRGreen System
kit following the manufacturers’ instructions. The Livak method,
2DDCt, was used to evaluate the relative expression of each target
gene.DCt was calculated by the difference between the Ct values of
the target gene and the b-actin or GAPDH endogenous housekeep-
ing gene. DDCt was obtained by subtracting the DCt of the calibra-
tor sample (TCPS) to the DCt of the sample. The results are
represented as 2DDCt and as gene expression relative to TCPS.
2.7. Statistical analysis
The normality of the data was verified with Shapiro–Wilk test.
All data was then statistically analyzed using non-parametric tests.
The unpaired one-tailed t-test with Welch’s correction for non-
parametric data was used (p 6 0.05).
3. Results and discussion
In the natural ECM, glycosaminoglycans presenting various
molecular arrangements, as well as different sulfation degrees
(SD), bind and stabilize GFs mainly by electrostatic interactions
[27–29]. Heparin, or synthetic heparin-analogue ending sulfate
groups, are widely used to stabilize and attract GFs [30–31]. Since
they present high affinity and the interactions are mainly electro-
static, the conformation and bioactivity of the GFs is usually pre-
served. Natural resources, including those from marine-origin,
offer a wide range of PEs with several molecular properties and
SD that may affect the incorporation of GFs from PL onto the
coatings [32–34]. Therefore, marine-origin polysaccharides wereTable 1
Sequences and melting temperature of the angiogenic genes analyzed.
Gene Primer sequence (Forward, Reverse 50–30) Tm (C)
b-actin ACTGGAACGGTGAAGGTGAC 59.5
AGAGAAGTGGGGTGGCTTTT
GAPDH ACAGTCAGCCGCATC 58.4
GACAAGCTTCCCGTTCTCAG
Integrin b3 ACCAGTAACCTGCGGATTGG 59.4
TCCGTGACACACTCTGCTTC
Integrin am CCGATTCCAAACTGGGAGCA 59.4
GGCCACTGAAGATGGAGCAT
Integrin a5 TGGCCTTCGGTTTACAGTCC 59.4
GGAGAGCCGAAAGGAAACCA
VEGFA GACAGATCACAGGTACAGGG 58.4
AGAAGCAGGTGAGAGTAAGC
FGFb GAGCAAATCTGCCCTGCTCA 59.4
TCCCGCATACTCTGGAGACA
Angiopoietin-1 GAAGGGAACCGAGCCTATTC 58.4
GGGCACATTTGCACATACAG
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stabilize, buildup and tune PL nanocoatings prepared by LbL
assembling [35]. We hypothesize that such combination of PEs
and PL could be an adequate strategy to deconstruct fundamental
structural and functional aspects of the extra-cellular matrix
towards the design of clinically relevant tissue engineering con-
structs able to stimulate angiogenesis [36]. PEs with different
charge and functional groups were combined with PL, namely:
alginate (Alg; 1) and chitosan (Chi; +1), as non-sulfated PEs;
and j-, i-, and k-carrageenan (jCar, iCar, kCar; 1, 2, 3 respec-
tively), as sulfated PEs; along with heparin (Hep; 3), as a control
sulfated PE. In a previous work [26], the capability of these PEs to
sequester fibroblast growth factor b (FGFb), vascular endothelial
growth factor A (VEGF A) and platelet derived growth factor
(PDGF) from PL during the assembling was analyzed. It has been
observed that the content of those GFs in the nanocoatings
(30–50 thick with 6 bilayers) was highly influenced by the nature
of the PE. Briefly, the sulfated PEs and Hep were able to adsorbed
higher levels of GFs; however, higher SD did not imply enhanced
incorporation. Namely, PDGF adsorption was decreased with the
increase of SD, while the highest contents of VEGF A reached were
detected on Hep and iCar. Interestingly, iCar was able to adsorb a
high amount of all the measured GFs. Consequently, higher SD
represented nanocoatings with increased VEGF A/PDGF and
FGFb/PDGF ratios suggesting them to be more adequate for the
morphogenic activation of EC.3.1. Endothelial cells adhesion
The HUVECs were seeded onto coatings of PL with 6 bilayers of
Alg/PL, Chi/PL, jCar/PL, iCar/PL, kCar/PL and Hep/PL, in the absence
of both EC growth supplement (ECGS) and Hep, and with varied
concentrations of fetal bovine serum (FBS, 0%, 10% and 20%) up
to 20 h – Fig. 2a.
In absence of serum, the adhesion of HUVECs was limited and
the number of cells in all the coatings and in the tissue culture
polystyrene (TCPS) was similar – Fig. 2a. Comparing to TCPS, with
10% FBS, cell adhesion was not significantly affected by the pre-
sence of the multilayers with exception of Alg and Chi (p < 0.05)
– Fig. 2b. Increasing the content of FBS to 20% has also not altered
much the adhesion of HUVECS relatively to TCPS – Fig. 2c. None-
theless, in presence of serum, HUVECS tended to adhere more on
iCar/PL6 (p < 0.05). On the other hand, the Chi/PL and Alg/PL nano-
coatings showed a tendency to impair cell adhesion (p < 0.05),
independently on the concentration of FBS.3.2. Endothelial cells morphology
The ability of those multilayers to activate ECs towards the for-
mation of tube-like structures (TLS) was also assessed. HUVECs
were seeded with a density of 100,000 cells/cm2 in presence of
10% FBS and their morphology was observed after 20 h of incuba-
tion. Fig. 3 and Fig. S1 show the HUVECs morphology on all the
assessed conditions. k/PL6 and Hep/PL6 induced considerably
higher cell cohesion, forming branching anastomosing tubes-like
with multicentric junctions giving rise to a network of TLS –
Fig. 4. No clear TLS were observed in Alg/PL6, Chi/PL6 nor i/PL6.
Although Chi and Alg PEs significantly adsorb PL [26], the nature
or stability of their pro-angiogenic cues were not enough to induce
the cellular assembling. In the case of i/PL, TLS structures were
observed under other cell density conditions (53,000 cells/cm2) –
Fig. S2. The ECs highly adhered onto i/PL6, which is believed to
consequently inhibit TLS formation. This might be caused by VE
cadherin complexationwith VEGF receptor, which inhibits its phos-
phorylation by VEGF and consequently the formation of TLS [37].ngiogenic nanocoatings, Acta Biomater. (2015), http://dx.doi.org/10.1016/j.
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affect the density of instructive proteins presented to the cells.
Thereby, the cell seeding density of HUVECs and the number of
bilayers of the k/PL pair were also varied. Respectively, 50,000,
100,000 and 150,000 cells/cm2 were seeded on k/PL6, and
100,000 cells/cm2 seeded on nanocoatings prepared with 1, 3 and
6 bilayers (k/PL1, k/PL3 and k/PL6) – Fig. 3. Total tube-length,Please cite this article in press as: S.M. Oliveira et al., Platelet lysate-based pro-a
actbio.2015.12.028number of meshes, number of nodes and master junctions formed
were quantified on fluorescence images (5) using Angiogenesis
Analyzer for Image J – Fig. 5. A single bilayer of k/PL was sufficient
to promote the formation of a network with 100,000 cells, which
total tube length could be increased with increasing number of
layers. With 6 bilayers, a lower cell density has shown to be more
adequate in obtaining a better network formation than with fewer
layers. This indicates that cell adhesion and TLS are dependent on
the number of bilayers and increasing the number of layers allows
a decrease of the required cell density.
Besides the total tube length, the number of nodes and meshes
were also influenced by the number of layers. It was observed a
tendency of increase all the features with the increasing of the
number of layers. In general, Hep/PL6 (100,000 cells) and k/PL6
(50,000 cells) have shown similar results, though a higher number
of total nodes was observed on kCar.
Cell Profiler was used to analyze cell form factor (i.e., round-
ness), eccentricity (i.e., elongation), major axis (i.e., cell length)
and minor axis (i.e., cell width) – Fig. S3. This analysis revealed that
under the tested conditions, the EC morphology was significantly
changed when seeded on the multilayers in comparison to TCPS.
While on TCPS cells show the normal cobblestone-like morphol-
ogy, they become rounder on the instructive multilayers (form fac-
tor closer to 1). However, on the multilayers that successfully
induced TLS, the cells elongation factor was similar to TCPS. Both
width and length decreased on the multilayers, thus not altering
significantly the elongation relatively to TCPS.ngiogenic nanocoatings, Acta Biomater. (2015), http://dx.doi.org/10.1016/j.
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Fig. 5. (a) Angiogenic parameters quantified with Angiogenesis Analyzer on cytoskeleton-stained images; (b) total tube length; (c) number of meshes; (d) number of nodes;
(e) number of master segments; (f) number of junctions. All pairs of samples were compared and significances are indicated with bars (p < 0.05, n = 6, mean ± sem).
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to be more elongated after 20–24 h of incubation. [38] Herein,
the surface properties (non-gel), the time of incubation and the cell
number may have caused the reduction of the size and the lack of
cytoskeleton elongation.3.3. Endothelial cells proliferation
In order to assess cell proliferation capability, the medium was
replaced with fresh medium with or without ECGS-Hep and cells
were incubated for more 3 days – Fig. 6a and b. Morphology was
observed after 4 days in culture – Fig. 6c. Even though the
initial media was changed, removing possible released GFs,
HUVECs kept some cell alignment after 4 days in culture on kPL6
(50,000 cells/cm2). On the other hand, in presence of ECGS cells
have lost the TLS and reached confluence.
Independently of the surface, in absence of growth supplement,
cells were unable to proliferate. In particular, Hep/PL6 has not sup-
ported cell viability, and cell number was slightly reduced
(p < 0.05) which suggests a lower pro-survival stimulation.
Medium supplementation with ECGS allowed a minimal
proliferation of the ECs, being this effect more pronounced on TCPS
(p < 0.05). Among the multilayers, i/PL6 showed the highestPlease cite this article in press as: S.M. Oliveira et al., Platelet lysate-based pro-a
actbio.2015.12.028HUVECs proliferation. This improvement might be related with
the higher capability of iCar to incorporate FGFb, which growth
factor is reported to be able of stimulating EC proliferation [39].
Nonetheless, the overall behavior suggested that these multilayers
do not promote ECs proliferation, and TLS formation in some cases.
This corroborates the reported tendency of matrices that lead to
extensive tubule formation (e.g., collagen IV, V and Matrigel) of
allowing only a minimal EC proliferation [6,40]. This proliferation
inhibition effect could be promoted by specific GFs that are simul-
taneously capable of eliciting the formation of TLS and inhibit EC
proliferation. For instance, transforming growth factor beta 1
(TGF-b1) induces angiogenesis through VEGF A-mediated apopto-
sis [41]. TGF-b1 is one of the multiple GF that can be found in PL.
The simultaneous presence of TGF-b1 and other GFs, rather than
only promoting angiogenesis or mitogenesis (e.g., by FGFb and
VEGF A, PDGF), could both elicit angiogenesis and impair prolifera-
tion or cell apoptosis.3.4. Angiogenic-gene expression
During the angiogenesis stages (activation, proliferation, migra-
tion and stabilization) the gene expression of the ECs is regulated
by several pro and anti-angiogenic factors. GFs such as VEGF Angiogenic nanocoatings, Acta Biomater. (2015), http://dx.doi.org/10.1016/j.
(a) (b) (c)
Fig. 6. Proliferation of HUVECs cultured with 10% FBS and in absence (a), or presence of ECGS-hep (b), after adhesion for 20 h (in absence of ECGS-hep and with 10% FBS). All
significances are indicate with: ⁄ (different to TCPS), # (different to all, after 4 days), (different to Chi/PL and Alg/PL) and bars (pair is different), (p < 0.05, n = 6; mean ± sem).
(c) HUVECs (k/PL6 50,000 cells/cm2) morphology after 4 days in culture showing some remaining TLS when cultured in absence of ECGS-hep (10%FBS), while in presence of
ECGS-hep (10%FBS) cells had disassembled, proliferated and reached confluence.
S.M. Oliveira et al. / Acta Biomaterialia xxx (2015) xxx–xxx 7and FGFb activate ECs and promote their proliferation. Integrin
such as a5, am, b3 play important roles during EC migration while
angiopoietin-1, PDGF and TGF-b regulate maturation and vessels
stabilization [8,42,43]. Herein, gene expression of VEGFA, FGFb,
integrins (a5, am and b3) and angiopoietin-1 were quantified after
20 h of culture – Fig. 7.
In accordance with the literature, the angiogenic-gene expres-
sion alterations during TLS formation are expected to be of small
magnitude (<2-fold) or even negative, as related to TCPS [42,44].
Indeed, for the majority of conditions, gene expression was similar
or significantly lower than TCPS with the exception of the
expression of VEGFA and angiopoietin-1. Regarding the expression
of integrins, k/PL6 (50,000 cells), k/PL3 (100,000 cells), i/PL6
(100,000 cells) and Hep/PL6 (100,000 cells) have, in general, shown
lower or similar expression to TCPS (p < 0.05). Exogenous FGFb is
known to be able to promote angiogenesis, both in vivo and in vitro,
by up-regulating the expression of VEGFA and the endogenous
VEGFA in ECs [45]. However, the expression of FGFb was decreased
on i/PL6 (100,000 cells), k/PL3 (100,000 cells), k/PL6 (50,000 cells),
k/PL6 (100,000 cells), with exception of Hep/PL6.0.0
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actbio.2015.12.028Both VEGFA and angiopoietin-1 are strong pro-angiogenic
factors with distinct functions and bidirectional dependent: one
up-regulates the other. While VEGFA causes vascular permeability,
angiopoietin-1 stabilizes the blood vessels and avoids plasma leak-
age induced by VEGFA [46,47]. Although being frequently related
with different angiogenesis stages, the simultaneously stimulation
of ECs with VEGFA and angiopoietin-1 has previously shown a
synergistic improvement of angiogenesis [48].
Recently, it has been reported that PRP contains high amounts of
angiopoietin-1 (300fold more than VEGFA) [16]. The same study
has shown that angiopoietin-1 and its respective cell receptor
(Tie2) are crucial in promoting angiogenesis when using a prepara-
tion of 250-fold diluted PRP.
Both the expression of VEGF A and angiopoietin-1 were
simultaneously increased with exception of TCPS, Alg/PL6 and i/
PL6. Angiopoietin-1 was increased even on the multilayers not
promoting TLS which suggests that surface VEGFA or FGFb (which
primarily up-regulates VEGFA [45]) might have up-regulated
angiopoietin-1 [49]. If a significant amount of angiopoietin-1 had
been incorporated in the coatings, this could up-regulate VEGFA*
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8 S.M. Oliveira et al. / Acta Biomaterialia xxx (2015) xxx–xxxexpression and VEGFA endogenous content, and consequently,
indirectly stimulate the formation of TLS [48,50,51].
3.5. Blockage of FGF/VEGF tyrosine kinase receptor
HUVECs were cultured in the presence of a FGF/VEGF tyrosine
kinase receptor inhibitor to understand whether the morphogenic
changes were driven by those pro-angiogenic GFs. This compound
could block the interaction of FGF and VEGF from the nanocoating,
or the soluble form, with their respective cell receptors (e.g., FGFR2
and VEGFR2). A condition that was shown to induce TLS was
selected: 50,000 cells/cm2 onto k/PL6. Cells were seeded with a
supplier’s recommended range of concentrations of inhibitor dis-
solved with DMSO (150 nM and 200 nM, containing 0.0075% v/v
and 0.01% v/v DMSO, respectively) or only with DMSO (0.0075%
v/v and 0.01% v/v of DMSO – named DMSO 150 and DMSO 200)
during 20 h. The use of DMSO as a solvent has diminished the
observed cellular density and made cells more elongated – Fig. 8.
However, the ability of HUVECS to be more cohesive and to align
was further reduced with the presence of the inhibitor and with
its increased concentration. No TLS were observed on the surfaces.
Cell Profiler analysis has not revealed significant cell shape differ-
ences between k/PL6 (50,000 cells) with inhibitor and only with
DMSO, both for 150 nM and for 200 nM – Fig. S3. DMSO is reported
as being able to decrease cell adhesion even at low concentrations
(1.55% v/v) [52]. Concentrations higher than 1% v/v have also been
reported to impair the formation of TLS on Matrigel [53]. Thereby,
one cannot exclude the inhibition of TLS and changes in cell
morphology to be in part caused by DMSO. Nonetheless, there
are indications that at least at some extent, FGF/VEGF has
mediated the formation of TLS.
The PL coatings assembled with the more sulfated polysacchar-
ides were able to induce a pro-angiogenic profile in HUVECs. This
strategy may be a cost-effective way to introduce pro-angiogenic
interfaces on surfaces or 3D scaffolds.
4. Conclusions
There is still a current need to develop cost effective cell-
interfaces able to promote angiogenesis and the formation of stable
vasculature.
PL is a source of several pro-angiogenic and other proteins
involved in the angiogenesis from the earliest to the maturation
phases. Herein, PL was incorporated in layer-by-layer assembled
nanocoatings with varied polysaccharides and number of layers.Please cite this article in press as: S.M. Oliveira et al., Platelet lysate-based pro-a
actbio.2015.12.028The nanocoatings prepared with the more sulfated polysaccharides
elicited the formation of tube-like structures in ECs within 20 h of
incubation. These morphogenic changes were accompanied by dif-
ferences in gene expressions, mainly higher VEGFA and higher
angiopoietin-1. Future work must be performed in order to clarify
the rule of PL as well as the in vivo behavior of the developed
structures.
Layer-by-Layer assembling including PL might be a simple
methodology to introduce and tune cost-effective pro-angiogenic
interfaces in 2D/3D biomaterials.
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